Pharmacists in Jefferson, LA Accepting Medicare

30 Pharmacists found. Showing 21 - 30

Dr. Harley N Evans, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 839 S Clearview Pkwy, Jefferson, LA 70121 Phone: 504-581-8876

Sarah Claire Cannon Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 839 S Clearview Pkwy, Jefferson, LA 70121 Phone: 504-581-8876

Miss Kristin Picou, BS Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 4327 Jefferson Hwy, Jefferson, LA 70121 Phone: 504-731-1431

Raenell Roche Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1415 Jefferson Hwy, Jefferson, LA 70121 Phone: 504-842-3205

Stacey Paul Laborde, PHARM.D Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 839 S Clearview Pkwy, Jefferson, LA 70121 Phone: 504-581-8876

Audry Ann Barrera Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1514 Jefferson Hwy, Jefferson, LA 70121 Phone: 504-833-2337

Danny Vo Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1801 Jefferson Hwy, Jefferson, LA 70121 Phone: 504-324-6632

Kerry Fine, PHARM.D. Pharmacist - Pharmacotherapy Medicare: Not Enrolled in Medicare Practice Location: 1512 Jefferson Hwy, Jefferson, LA 70121 Phone: 504-842-2843    Fax: 504-842-6599

Kristina Ann Dupre, PHARMD Pharmacist - Pharmacist Clinician (PhC)/ Clinical Pharmacy Specialist Medicare: Not Enrolled in Medicare Practice Location: 1514 Jefferson Hwy, Jefferson, LA 70121 Phone: 504-842-0308

James S. Wimberly Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 3623 Jefferson Hwy, Jefferson, LA 70121 Phone: 504-831-3272    Fax: 504-831-3272

News Archive

Russian Ministry of Health approves Medivir's simeprevir for chronic hepatitis C genotype 1 infection

Medivir AB announced today that the Russian Ministry of Health has approved Sovriad (simeprevir) for the treatment of chronic hepatitis C genotype 1 infection, in combination with peginterferon alfa and ribavirin, in adults with compensated liver disease (including cirrhosis) who are treatment naïve or who have failed previous interferon therapy (pegylated or non-pegylated) with or without ribavirin. Russia will be the first country within EMEA to gain access to simeprevir, which represents a significant advance in hepatitis C treatment.

Drought-resistant native shrub can irrigate food crops, study finds

The trick to boosting crops in drought-prone, food-insecure areas of West Africa could be a ubiquitous native shrub that persists in the toughest of growing conditions.

Type 2 diabetes and insulin use associated with CRC risk in men, but not women

There is an association between type 2 diabetes mellitus and colorectal cancer (CRC) among men, but not women, according to a new study in Gastroenterology, the official journal of the American Gastroenterological Association (AGA) Institute.

UC Davis Health begins administering Pfizer/BioNTech Covid-19 booster shots to patients

Based on the recent release of the U.S. Centers for Disease Control and Prevention recommendations for a third dose of the Pfizer/BioNTech Covid-19 vaccine, UC Davis Health began administering booster shots to patients at its area clinics and to employees on the medical campus today.

JDRF-funded researchers find that beta cell stress may play vital role in the onset of type 1 diabetes

In the healthy pancreas of someone without type 1 diabetes (T1D), the hormone insulin (essential for turning food into energy) is produced, stored, and released in a normal "factory-like" process within pancreatic beta cells in response to glucose in the diet.

Read more Medical News

› Verified 4 days ago

• 1
• 2(current)